Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Effect of Web-based Training and Telephone Monitoring on Patients With Heart Failure

21. desember 2019 oppdatert av: Emine İLASLAN, Akdeniz University

The Effect of Web Based Training and Telephone Follow-up on Symptom Management and Quality of Life in Patients With Heart Failure

Web-based training and telephone monitoring have an effect on reducing symptom burden in patients with heart failure.

Web-based training and telephone monitoring have an effect on improving the quality of life of patients with heart failure.

Web-based training and telephone follow-up have an effect on reducing recurrent hospitalizations of patients with heart failure.

Web-based training and telephone follow-up have a positive effect on the clinical parameters (weight, waist circumference, blood pressure, creatinine) of patients with heart failure.

Studieoversikt

Detaljert beskrivelse

The aim of this study was to determine the effect of web-based training and telephone monitoring on symptom management and quality of life in patients with heart failure. Study was conducted with the participation of 32 intervention and 32 control patients who have heart failure, in Akdeniz University Hospital Cardiology Clinic, between April 2018 and July 2019. Data were collected using the Patient Information Form, Left Ventricular Dysfunction Scale and Memorial Symptom Rating Scale-Heart Failure Scale, Website Analysis and Measurement Inventory. The patients in the intervention group received web-based training after discharge, and were followed up by telephone at the first, fourth, eighth and 12 weeks. The scale data were collected before the patient was discharged from hospital and at the third month of discharge.

Studietype

Intervensjonell

Registrering (Faktiske)

70

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Antalya, Tyrkia
        • Akdeniz University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Undergoing treatment at the Cardiology Clinic of Akdeniz University Hospital with a diagnosis of heart failure.
  • Class I, II, III according to NYHA classification
  • Has internet access and can use a computer / tablet or smartphone
  • Agree to participate in the research

Exclusion Criteria:

  • Functional class IV according to NYHA classification
  • Diagnosed with psychiatric illness
  • Malignancy diagnosed
  • Visually and hearing impaired
  • Diagnosed with chronic obstructive pulmonary disease

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: web-based training and telephone monitoring
The heart failure patients in the intervention group were given web-based training for three months after discharge and followed up by telephone at the first, fourth, eighth and 12th weeks. At the same time, a text message was sent once a week. Scale data were collected before the patient was discharged from the hospital and at the third month of discharge.
web-based training and telephone monitoring and short message

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Has an effect on reducing symptom burden
Tidsramme: 3 months
Memorial Symptom Assessment Scale-Heart Failure: The Memorial Symptom Assessment Scale-Heart Failure was used to evaluate symptom prevalence, severity, and distress. For each of the 32 items, the patient indicated whether he/she had experienced the symptom by selecting "yes" or "no." If "yes" was selected, the severity of a symptom over the past 7 days was assessed using the response. The score range of each symptom is 0-4. Higher score indicates a higher symptom burden. Turkish version of the questionnaire was used.
3 months
Has an effect on improving quality of life
Tidsramme: 3 months
Left Ventricular Dysfunction Questionnaire: The questionnaire is a 36 item questionnaire for patients with left ventricular dysfunction. Responses are dichotomous (true or false). True responses are summed and the sum is expressed as a percentage. The score range of scale is 0-100. A higher score indicates a worse quality of life. Turkish version of the questionnaire was used.
3 months
Reducing heart failure patient rehospitalizations
Tidsramme: 3 months
Evaluation form of rehospitalizations: During the 3-month follow-up period, the number of admissions to the hospital and emergency outpatient clinic was recorded. In addition, if he was hospitalized, how many days he was hospitalized was recorded.
3 months
Positive effects on waist circumference
Tidsramme: 3 months
Waist circumference assessment form: The form was prepared by the researcher to record the waist circumference of the patients as "centimeters" unit.
3 months
Positive effects on weight
Tidsramme: 3 months
Weight assessment form: The form was prepared by the researcher to record the patients' weights in "kilogram" units.
3 months
Positive effects on blood pressure
Tidsramme: 3 months
Blood pressure assessment form: The form was prepared by the researcher to record the blood pressure of the patients as "mmHg" units
3 months
Positive effects on creatinine
Tidsramme: 3 months
Creatinine assessment form: A form was prepared by the researcher to record normal creatinine levels in the blood as "milligram" units.
3 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. april 2018

Primær fullføring (Faktiske)

1. august 2019

Studiet fullført (Forventet)

1. januar 2020

Datoer for studieregistrering

Først innsendt

19. desember 2019

Først innsendt som oppfylte QC-kriteriene

21. desember 2019

Først lagt ut (Faktiske)

24. desember 2019

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

24. desember 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

21. desember 2019

Sist bekreftet

1. desember 2019

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • Akdeniz University 07

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

All collected IPD will share

IPD-delingstidsramme

starting 1 months after publication

Tilgangskriterier for IPD-deling

all people access

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • CSR

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Hjertefeil

3
Abonnere